NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
NervGen Pharma cash
Cash and short-term investments held at the end of each period.
NervGen Pharma's cash was C$22.07M at Dec 31, 2025. For fiscal 2025 it was C$22.07M, up 27.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | C$22.07M | +27.8% |
| FY2024 | Dec 31, 2024 | C$17.27M | +48.1% |
| FY2023 | Jan 1, 2024 | C$11.66M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | C$22.07M | – |
| Q4 FY2024 | Dec 31, 2024 | C$17.27M | – |
| Q4 FY2023 | Jan 1, 2024 | C$11.66M | – |
See a number that looks wrong?